ENDOLOGIX INC's ticker is and the CUSIP is 29266SAA4. A total of 18 filers reported holding ENDOLOGIX INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $4,584,000 | +14.2% | 5,000,000 | -9.1% | 4.13% | +1.2% |
| Q1 2016 | $4,015,000 | -17.3% | 5,500,000 | -8.3% | 4.08% | -1.0% |
| Q4 2015 | $4,856,000 | -9.1% | 6,000,000 | 0.0% | 4.12% | +1.3% |
| Q3 2015 | $5,340,000 | -17.2% | 6,000,000 | -10.4% | 4.07% | +1.7% |
| Q2 2015 | $6,446,000 | +0.2% | 6,693,000 | +3.9% | 4.00% | +25.7% |
| Q1 2015 | $6,435,000 | +31.6% | 6,443,000 | +28.9% | 3.18% | +32.4% |
| Q4 2014 | $4,891,000 | +9.0% | 5,000,000 | 0.0% | 2.40% | +9.8% |
| Q3 2014 | $4,488,000 | -10.4% | 5,000,000 | 0.0% | 2.19% | -12.4% |
| Q2 2014 | $5,009,000 | +5.5% | 5,000,000 | 0.0% | 2.50% | +36.5% |
| Q1 2014 | $4,747,000 | +16.8% | 5,000,000 | +25.0% | 1.83% | +65.2% |
| Q4 2013 | $4,063,000 | – | 4,000,000 | – | 1.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 51,117,000 | $46,140,000 | 1.90% |
| PFM Health Sciences, LP | 6,445,000 | $5,809,000 | 0.16% |
| Partner Investment Management, L.P. | 84,000 | $76,000 | 0.10% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 5,562,000 | $5,013,000 | 0.09% |
| OAKTREE CAPITAL MANAGEMENT LP | 6,000,000 | $5,423,000 | 0.08% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,095,000 | $1,004,000 | 0.04% |
| ACUTA CAPITAL PARTNERS, LLC | 96,000 | $86,000 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,500,000 | $1,352,000,000 | 0.03% |
| AMUNDI ASSET MANAGEMENT US, INC. | 7,305,000 | $6,557,000 | 0.02% |
| Citadel Advisors | 6,230,000 | $5,624,000 | 0.01% |